Xing Wan

587 total citations · 1 hit paper
43 papers, 410 citations indexed

About

Xing Wan is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xing Wan has authored 43 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Xing Wan's work include Pharmacological Effects of Natural Compounds (3 papers), Sirtuins and Resveratrol in Medicine (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). Xing Wan is often cited by papers focused on Pharmacological Effects of Natural Compounds (3 papers), Sirtuins and Resveratrol in Medicine (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). Xing Wan collaborates with scholars based in China, Australia and United Kingdom. Xing Wan's co-authors include Xiujuan Qu, Xiaofang Che, Hong Liu, Xianbing Chen, Ning Chen, Yong Sun, E.H. Tan, Jinlan Zhang, Yanjuan Hou and D. Huang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Annals of Oncology.

In The Last Decade

Xing Wan

34 papers receiving 408 citations

Hit Papers

Mitochondrial oxidative damage reprograms lipid metabolis... 2024 2026 2025 2024 10 20 30 40 50

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xing Wan China 11 239 104 55 42 31 43 410
Guoxiong Han China 3 229 1.0× 131 1.3× 53 1.0× 37 0.9× 23 0.7× 5 434
Yuhai Gu China 3 236 1.0× 137 1.3× 51 0.9× 36 0.9× 24 0.8× 8 443
Jun Pan China 13 273 1.1× 123 1.2× 74 1.3× 36 0.9× 40 1.3× 24 525
Xiaochun Lin China 12 201 0.8× 104 1.0× 48 0.9× 75 1.8× 36 1.2× 35 406
Yuan Dong China 11 210 0.9× 95 0.9× 57 1.0× 63 1.5× 30 1.0× 31 415
Yuyang Zheng China 12 215 0.9× 77 0.7× 28 0.5× 37 0.9× 29 0.9× 15 357
Eman Khairy Egypt 12 158 0.7× 82 0.8× 36 0.7× 50 1.2× 26 0.8× 25 340
Anindya Roy Chowdhury India 12 257 1.1× 74 0.7× 44 0.8× 57 1.4× 32 1.0× 20 456
Dan Song China 14 180 0.8× 70 0.7× 59 1.1× 54 1.3× 32 1.0× 41 497

Countries citing papers authored by Xing Wan

Since Specialization
Citations

This map shows the geographic impact of Xing Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xing Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xing Wan more than expected).

Fields of papers citing papers by Xing Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xing Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xing Wan. The network helps show where Xing Wan may publish in the future.

Co-authorship network of co-authors of Xing Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Xing Wan. A scholar is included among the top collaborators of Xing Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xing Wan. Xing Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Jun, Lei Xing, Ying Sun, et al.. (2025). A Device for the Removal of Peripheral Blood Circulating Tumor Cells and Inhibiting Their Biodistribution. Nano Biomedicine and Engineering. 17(3). 386–401.
2.
3.
4.
Wan, Xing, et al.. (2025). The NR3C2-SIRT1 signaling axis promotes autophagy and inhibits epithelial mesenchymal transition in colorectal cancer. Cell Death and Disease. 16(1). 295–295. 1 indexed citations
5.
Wan, Xing, et al.. (2025). Cistanche deserticola polysaccharides protect against cyclophosphamide-induced premature ovarian failure in mice by regulating the JAK-STAT pathway. Journal of Ethnopharmacology. 349. 119971–119971. 2 indexed citations
6.
Wan, Xing, et al.. (2025). Research progress of ASIC family in tumors. Experimental Cell Research. 450(2). 114681–114681.
7.
Wan, Xing, et al.. (2025). Cistanche deserticola polysaccharides enhance female germline stem cell differentiation through BMP/SMAD signaling to mitigate premature ovarian failure. International Journal of Biological Macromolecules. 304(Pt 2). 140848–140848. 3 indexed citations
8.
Wan, Xing, et al.. (2024). High glucose inhibits autophagy and promotes the proliferation and metastasis of colorectal cancer through the PI3K/AKT/mTOR pathway. Cancer Medicine. 13(11). e7382–e7382. 9 indexed citations
9.
Hou, Xuefeng, Kun Chen, Xing Wan, et al.. (2024). Intratumoral and peritumoral radiomics for preoperative prediction of neoadjuvant chemotherapy effect in breast cancer based on 18F-FDG PET/CT. Journal of Cancer Research and Clinical Oncology. 150(11). 484–484. 5 indexed citations
10.
Wan, Xing, et al.. (2024). ASIC3-activated key enzymes of de novo lipid synthesis supports lactate-driven EMT and the metastasis of colorectal cancer cells. Cell Communication and Signaling. 22(1). 388–388. 2 indexed citations
11.
12.
13.
Wang, Jiajian, Tingting Wang, Sidi Li, et al.. (2023). Single-cell communication patterns and their intracellular information flow in synovial fibroblastic osteoarthritis and rheumatoid arthritis. Immunology Letters. 263. 1–13. 9 indexed citations
14.
Niu, Huimin, E.H. Tan, Xing Wan, et al.. (2023). CD36 deletion ameliorates diabetic kidney disease by restoring fatty acid oxidation and improving mitochondrial function. Renal Failure. 45(2). 2292753–2292753. 15 indexed citations
15.
Li, Yiming, et al.. (2023). Identification and immunological characterization of lipid metabolism-related molecular clusters in nonalcoholic fatty liver disease. Lipids in Health and Disease. 22(1). 124–124. 7 indexed citations
16.
Kong, Yanjie, Wenlong Ren, Naseer Ali Shah, et al.. (2022). Histone Deacetylase Inhibitors (HDACi) Promote KLF5 Ubiquitination and Degradation in Basal-like Breast Cancer. International Journal of Biological Sciences. 18(5). 2104–2115. 19 indexed citations
17.
Zhang, Ye, Xiujuan Qu, Xiaofang Che, et al.. (2017). miR‐200a enhances TRAIL‐induced apoptosis in gastric cancer cells by targeting A20. Cell Biology International. 42(5). 506–514. 24 indexed citations
18.
Wan, Xing, Hong Liu, Yong Sun, et al.. (2017). Lunasin: A promising polypeptide for the prevention and treatment of cancer. Oncology Letters. 13(6). 3997–4001. 36 indexed citations
19.
Wan, Xing, et al.. (2017). Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1α-dependent and -independent mechanism. PLoS ONE. 12(9). e0184213–e0184213. 22 indexed citations
20.
Wan, Xing. (2012). Heparin Added in Total Nutrient Admixture for Preventing Peripherally Inserted Central Catheter Occlusion in Neonate:A Case Report. Zhongguo xunzheng yixue zazhi. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026